Ternary complex factor-serum response factor complex-regulated gene activity is required for cellular proliferation and inhibition of apoptotic cell death

Molecular and Cellular Biology

Volumn 24, Issue 23, 2004, Pages 10340-10351

  Vickers, Elaine R ^a   Kasza, Aneta ^a   Kurnaz, Isil Aksan ^a,b   Seifert, Anne ^a   Zeef, Leo A H ^a   O'Donnell, Amanda ^a   Hayes, Andy ^a   Sharrocks, Andrew D ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b YEDITEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MCL 1; SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR ELK 1;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DOWN REGULATION; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

ALLELES; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; DOWN-REGULATION; FLOW CYTOMETRY; GENES, REPORTER; GENETIC VECTORS; HELA CELLS; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MICROSCOPY, FLUORESCENCE; MITOGENS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTEIN STRUCTURE, TERTIARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERUM RESPONSE FACTOR; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

CERVUS ELAPHUS;

EID: 8644243021     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.23.10340-10351.2004     Document Type: Article

References (61)

1. Alexandropoulos, K., S. A. Qureshi, M. Rim, V. P. Sukhatme, and D. A. Foster. 1992. v-Fps-responsiveness in the Egr-1 promoter is mediated by serum response elements. Nucleic Acids Res. 20:2355-2359.
2. Ayadi, A., H. Zheng, P. Sobieszczuk, G. Buchwalter, P. Moerman, K. Alitalo, and B. Wasylyk. 2001. Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1. EMBO J. 20:5139-5152.
3. Badiani, P., P. Corbella, D. Kioussis, J. Marvel, and K. Weston. 1994. Dominant interfering alleles define a role for c-Myb in T-cell development. Genes Dev. 8:770-782.
4. Bertolotto, C., J. E. Ricci, F. Luciano, B. Mari, J. C. Chambard, and P. Auberger. 2000. Cleavage of the serum response factor during death receptor-induced apoptosis results in an inhibition of the c-FOS promoter transcriptional activity. J. Biol. Chem. 275:12941-12947.
5. Cesari, F., S. Brecht, K. Vintersten, L. G. Vuong, M. Hofmann, K. Klingel, J. J. Schnorr, S. Arsenian, H. Schild, T. Herdegen, F. F. Wiebel, and A. Nordheim. 2004. Mice deficient for the Ets transcription factor Elk-1 show normal immune responses and mildly impaired neuronal gene activation. Mol. Cell. Biol. 24:294-305.
6. Christy, B., and D. Nathans. 1989. Functional serum response elements upstream of the growth factor-inducible gene zif268. Mol. Cell. Biol. 9:4889-4895.
7. Clarkson, R. W., C. A. Shang, L. K. Levitt, T. Howard, and M. J. Waters. 1999. Ternary complex factors Elk-1 and Sap-1a mediate growth hormone-induced transcription of egr-1 (early growth response factor-1) in 3T3-F442A preadipocytes. Mol. Endocrinol. 13:619-631.
8. Costello, P. S., R. H. Nicolas, Y. Watanabe, I. Rosewell, and R. Treisman. 2004. Ternary complex factor SAP-1 is required for Erk-mediated thymocyte positive selection. Nat. Immunol. 5:289-298.
9. Criqui-Filipe, P., C. Ducret, S. M. Maira, and B. Wasylyk. 1999. Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation. EMBO J. 18:3392-3403.
10. Cuconati, A., C. Mukherjee, D. Perez, and E. White. 2003. DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes Dev. 17:2922-2932.
11. Dalton, S., and R. Treisman. 1992. Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element. Cell 68:597-612.
12. Datta, R., E. Rubin, V. Sukhatme, S. Qureshi, D. Hallahan, R. R. Weichselbaum, and D. W. Kufe. 1992. Ionizing radiation activates transcription of the EGR1 gene via CArG elements. Proc. Natl. Acad. Sci. USA 89:10149-10153.
13. Dotto, G. P. 2000. p21(WAF1/Cip1): more than a break to the cell cycle? Biochim. Biophys. Acta 1471:M43-M56.
14. Drewett, V., A. Devitt, J. Saxton, N. Portman, P. Greaney, N. E. Cheong, T. F. Alnemri, E. Alnemri, and P. E. Shaw. 2001. Serum response factor cleavage by caspases 3 and 7 linked to apoptosis in human BJAB cells. J. Biol. Chem. 276:33444-33451.
15. Ducret, C., S. M. Maira, Y. Lutz, and B. Wasylyk. 2000. The ternary complex factor Net contains two distinct elements that mediate different responses to MAP kinase signalling cascades. Oncogene 19:5063-5072.
16. Fitzsimmons, D., W. Hodsdon, W. Wheat, S. M. Maira, B. Wasylyk, and J. Hagman. 1996. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev. 10:2198-2211.
17. TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358:414-417.
18. Gineitis, D., and Treisman, R. 2001. Differential usage of signal transduction pathways defines two types of serum response factor target gene. J. Biol. Chem. 276:24531-24539.
19. Hassler, M., and T. J. Richmond. 2001. The B-box dominates SAP-1-SRF interactions in the structure of the ternary complex. EMBO J. 20:3018-3028.
20. Herrera, R. E., P. E. Shaw, and A. Nordheim. 1989. Occupation of the c-fos serum response element in vivo by a multi-protein complex is unaltered by growth factor induction. Nature 340:68-70.
21. Hill, C. S., R. Marais, S. John, J. Wynne, S. Dalton, and R. Treisman. 1993. Functional analysis of a growth factor-responsive transcription factor complex. Cell 73:395-406.
22. TCF. Nature 354:531-534.
23. Janknecht, R., and A. Nordheim, A. 1992. Elk-1 protein domains required for direct and SRF-assisted DNA-binding. Nucleic Acids Res. 20:3317-3324.
24. Jaynes, J. B., and P. H. O'Farrell. 1991. Active repression of transcription by the engrailed homeodomain protein. EMBO J. 10:1427-1433.
25. Kang, K. H., W. H. Kim, and K. H. Choi. 1999. p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells. Exp. Cell Res. 253:403-412.
26. Latinkic, B. V., M. Zeremski, and L. F. Lau. 1996. Elk-1 can recruit SRF to form a ternary complex upon the serum response element. Nucleic Acids Res. 24:1345-1351.
27. Li, Q. J., S. Vaingankar, F. M. Sladek, and M. Martins-Green. 2000. Novel nuclear target for thrombin: activation of the Elk1 transcription factor leads to chemokine gene expression. Blood 96:3696-3706.
28. Ling, Y., J. H. Lakey, E. C. Roberts, and A. D. Sharrocks. 1997. Molecular characterization of the B-box protein-protein interaction motif of the ETS-domain transcription factor Elk-1. EMBO J. 16:2431-2440.
29. Maira, S. M., J. M. Wurtz, and B. Wasylyk. 1996. Net (ERP/SAP2), one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif. EMBO J. 15:5849-5865.
30. Mansour, S. J., Matten, W. T., Hermann, A. S. Candia, J. M. Rong, S. Fukasawa, K. Vande, G. F. Woude, and N. G. Ahn. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265:966-970.
31. Matsushita, H., R. Morishita, I. Kida, M. Aoki, S. Hayashi, N. Tomita, K. Yamamoto, A. Moriguchi, A. Noda, Y. Kaneda, J. Higaki, and T. Ogihara. 1998. Inhibition of growth of human vascular smooth muscle cells by overexpression of p21 gene through induction of apoptosis. Hypertension 31:493-498.
32. May, P., and E. May. 1999. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18:7621-7636.
33. Mora-Garcia, P., and K. M. Sakamoto. 2000. Granulocyte colony-stimulating factor induces Egr-1 up-regulation through interaction of serum response element-binding proteins. J. Biol. Chem. 275:22418-22426.
34. Moulding, D. A., R. V. Giles, D. G. Spiller, M. R. White, D. M. Tidd, and S. W. Edwards. 2000. Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells. Blood 96:1756-1763.
35. Murai, K., and R. Treisman. 2002. Interaction of serum response factor (SRF) with the Elk-1 B box inhibits RhoA-actin signaling to SRF and potentiates transcriptional activation by Elk-1. Mol. Cell. Biol. 22:7083-7092.
36. Nijhawan, D., M. Fang, E. Traer, Q. Zhong, W. Gao, F. Du, and X. Wang. 2003. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev. 17:1475-1486.
37. Price, M. A., A. E. Rogers, and R. Treisman. 1995. Comparative analysis of the ternary complex factors Elk-1, SAP-1a and SAP-2 (ERP/NET). EMBO J. 14:2589-2601.
38. Qureshi, S. A., X. M. Cao, V. P. Sukhatme, and D. A. Foster. 1991. v-Src activates mitogen-responsive transcription factor Egr-1 via serum response elements. J. Biol. Chem. 266:10802-10806.
39. Rim, M., S. A. Qureshi, D. Gius, J. Nho, V. P. Sukhatme, and D. A. Foster. 1992. Evidence that activation of the Egr-1 promoter by v-Raf involves serum response elements. Oncogene 7:2065-2068.
40. Roberts, E. C., R. W. Deed, J. D. Norton, and A. D. Sharrocks. 2001. Id helix-loop-helix proteins antagonize the activity of Pax transcription factors by inhibiting DNA binding. Mol. Cell. Biol. 21:524-533.
41. Robinson, M. J., and M. H. Cobb. 1997. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9:180-186.
42. Schratt, G., B. Weinhold, A. S. Lundberg, S. Schuck, J. Berger, H. Schwarz, R. Weinberg, U. Rüther, and A. Nordheim. 2001. Serum response factor is required for immediate-early gene activation yet is dispensable for proliferation of embryonic stem cells. Mol. Cell. Biol. 21:2933-2943.
43. Schratt, G., U. Philippar, D. Hockemeyer, H. Schwarz, S. Alberti, and A. Nordheim. 2004. SRF regulates Bcl-2 expression and promotes cell survival during murine embryonic development. EMBO J. 23:1834-1844.
44. Seth, A., F. A. Gonzalez, S. Gupta, D. L. Raden, and R. J. Davis. 1992. Signal transduction within the nucleus by mitogen-activated protein kinase. J. Biol. Chem. 267:24796-24804.
45. Shao, N., T. Chai, J. Q. Cui, N. Wang, K. Aysola, E. S. Reddy, and V. N. Rao. 1998. Induction of apoptosis by Elk-1 and deltaElk-1 proteins. Oncogene 17:527-532.
46. Sharrocks, A. D. 2002. Complexities in ETS-domain transcription factor function and regulation; lessons from the TCF subfamily. Biochem. Soc. Trans. 30:1-9.
47. Sharrocks, A. D., F. von Hesler, and P. E. Shaw. 1993. The identification of elements determining the different DNA binding specificities of the MADS box proteins p67SRF and RSRFC4. Nucleic Acids Res. 21:215-221.
48. SRF: implications for a novel DNA-binding motif. Mol. Cell. Biol. 13:123-132.
49. Sharrocks, A. D., A. Galanis, and S.-H. Yang. 2000. Docking domains and substrate specificity determination for the MAP kinases. Trends Biochem. Sci. 24:448-453.
50. Shaw, P. E., and J. Saxton. 2003. Ternary complex factors: prime nuclear targets for mitogen-activated protein kinases. Int. J. Biochem. Cell Biol. 35:1210-1226.
51. Sheikh, M. S., M. Garcia, Q. Zhan, Y. Liu and A.J. Fornace, Jr. 1996. Cell cycle-independent regulation of p21Waf1/Cip1 and retinoblastoma protein during okadaic acid-induced apoptosis is coupled with induction of Bax protein in human breast carcinoma cells. Cell Growth Differ. 7:1599-1607.
52. Shore, P., and A. D. Sharrocks. 1994. The transcription factors Elk-1 and serum response factor interact by direct protein-protein contacts mediated by a short region of Elk-1. Mol. Cell. Biol. 14:3283-3291.
53. Townsend, K. J., P. Zhou, L. Qian, C. K. Bieszczad, C. H. Lowrey, A. Yen, and R. W. Craig. 1999. Regulation of MCL1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation. J. Biol. Chem. 274:1801-1813.
54. Treisman, R. 1996. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8:205-215.
55. Treisman, R., R. Marais, and J. Wynne. 1992. Spatial flexibility in complexes between SRF and its accessory proteins. EMBO J. 11:4631-4640.
56. Tsai, E., J. V. Falvo, A. V. Tsytsykova, A. K. Barczak, A. M. Reimold, L. H. Glimcher, M. J. Fenton, D. C. Gordon, I. F. Dunn, and A. E. Goldfeld. 2000. A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol. Cell. Biol. 20:6084-6094.
57. Vickers, E. R., and A. D. Sharrocks. 2002. The use of inducible engrailed fusion proteins to study the cellular functions of eukaryotic transcription factors. Methods 26:270-280.
58. Wasylyk, B., J. Hagman, and A. Gutierrez-Hartmann. 1998. Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signalling pathway. Trends Biochem. Sci. 23:213-216.
59. Withers, D. A., and S. Hakomori. 2000. Human alpha (1,3)- fucosyltransferase IV (FUTIV) gene expression is regulated by elk-1 in the U937 cell line. J. Biol. Chem. 275:40588-40593.
60. Yang, S.-H., P. R. Yates, A. J. Whitmarsh, R. J. Davis, and A. D. Sharrocks. 1998. The Elk-1 ETS-domain transcription factor contains a mitogen-activated protein kinase targeting motif. Mol. Cell. Biol. 18:710-720.
61. Yang, S. H., P. Shore, N. Willingham, J. H. Lakey, and A. D. Sharrocks. 1999. The mechanism of phosphorylation-inducible activation of the ETS-domain transcription factor Elk-1. EMBO J. 18:5666-5674.